|
|
||||
16/03/2026 08:00
SEGRO PUBLIC LIMITED COMPANY : DATA CENTRE UPDATE
p16 March 2026/p
p align=centerstrongSEGRO plc "SEGRO"/strong/p
p align=centerstrongDATA CENTRE UPDATE/strong/p
pSEGRO, a leading owner, manager and developer of modern warehouses, industrial property and data centres, provides an update on its 2.5GW data centre...
Lire...
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
p
EQSNews: Mutares SE & Co. KGaA
/ Key words: Preliminary Results/Investment
br/
Mutares posts another record year: According to preliminary, unaudited figures, Mutares increases Group...
Lire...
16/03/2026 07:30
ORPHAN SYNERGY EUROPE-PHARMA : OSE Immunotherapeutics Announces its 2026 Financial Calendar
OSE Immunotherapeutics Announces its 2026 Financial Calendar
Nantes, France, March 16, 2026 – 7:30am CET OSE Immunotherapeutics SA ISIN: FR0012127173;
Mnemo: OSE, today announced its financial calendar for 2026.
Information ...
Lire...
16/03/2026 07:24
EQS-Adhoc: UBS AG: UBS publishes agenda for its Annual General Meeting on 15 April 2026
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
pEQSAdhoc: UBS AG / Key words: Other/Otherbr/
UBS AG: UBS publishes agenda for its Annual General Meeting on 15 April 2026 br/br/
16March2026 / 07:24 CET/CESTbr/
Disclosure of an inside information...
Lire...
16/03/2026 07:05
EQS-News: Hypoport delivers solid gross margin growth and disproportionate EBIT increase in 2025
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
p
EQSNews: Hypoport SE
/ Key words: Preliminary Results/Annual Results
br/
Hypoport delivers solid gross margin growth and disproportionate EBIT increase in 2025 br/br/
16.03.2026 /...
Lire...
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
p
Julius Baer Group Ltd.
/ Key words: Personnel
br/
Changes to the Board of Directors of Julius Baer Group br/br/
16.03.2026 / 07:02 CET/CESTbr/br//p
hr/divdivpZurich, 16 March...
Lire...
16/03/2026 07:00
BioVersys AG : BioVersys Receives Green Light from US FDA for BV100 HABP/VABP Phase 3 Pivotal Trial Start
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= cellpadding= cellspacing= trtd
pBioVersys AG / Key words: Regulatory Admission/Studybr/
BioVersys Receives Green Light from US FDA for BV100 HABP/VABP Phase 3 Pivotal Trial Start br/br/span16March2026 / 07:00...
Lire...
16/03/2026 06:59
Julius Baer Group Ltd. : Julius Baer publishes Annual Report 2025 and Sustainability Report 2025
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
pJulius Baer Group Ltd. / Key words: Miscellaneous/Sustainabilitybr/
Julius Baer publishes Annual Report 2025 and Sustainability Report 2025 br/br/
16March2026 / 06:59 CET/CESTbr/
Release of an ad hoc...
Lire...
Press contact
Fahd Pasha
Tel.: 1 647 860 3777
...
Lire...
|
|
||||